Keywords
Curation
Ncbi
Racine
Curation
Checkpoint
Ncbi
Racine
Ncbi
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Indans (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Indans (administration & dosage) < Indans (adverse effects) < Indans (chemistry)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000347 (2003) Olivier Rascol [France]Monoamine oxidase inhibitors--is it time to up the TEMPO?
000506 (????) O. Rascol [France] ; D J Brooks ; E. Melamed ; W. Oertel ; Werner Poewe ; F. Stocchi ; E. TolosaRasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
000683 (2006) Rasagiline. Parkinson's disease: a simple me-too.
000775 (2007) Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
000C97 (2011) Santiago Perez-Lloret [France] ; Olivier RascolSafety of rasagiline for the treatment of Parkinson's disease.
001017 (2013) François Viallet [France] ; Séverine Pitel ; Sylvie Lancrenon ; Olivier BlinEvaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson's disease.
001101 (2013) Fanny Duval [France] ; Olivier Flabeau ; Julien Razafimahefa ; Umberto Spampinato ; François TisonEncephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.
001350 (????) Romain Lefaucheur [France] ; Damien Fetter ; Gaëlle Gaillon ; Alaina Borden ; David MaltêteTendon rupture as an adverse effect of rasagiline.
001371 (2014) P. Cesaro [France] ; L. Defebvre [France][Drug treatment of early-stage (de novo and "honeymoon") Parkinson disease].
001835 (2015) Romain Lefaucheur [France] ; Floriane Le Goff [France] ; Gaëlle Gaillon [France] ; Aude Triquenot-Bagan [France] ; David Maltête [France]Severe dizziness following rivaroxaban introduction in a parkinsonian patient: Drug-drug interaction?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Indans (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Indans (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Indans (adverse effects)
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024